HDTRA121F0005↗
Leidos, Inc. received this contract from Defense Threat Reduction Agency, Defense Threat Reduction Agency: $17.33M obligated so far for national defense r&d services; defense-related activities; applied research. Its period of performance ended 2025-12-02.
Key facts · data as of Oct 23, 2026
- Recipient
- Leidos, Inc.
- Awarding agency
- Defense Threat Reduction Agency (Department of Defense)
- Contracting office
- Defense Threat Reduction Agency (HDTRA1)
- Obligated to date
- $17.33M
- Potential value
- $41.76M
- Ends
- 2025-12-02
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award HDTRA121F0005, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_HDTRA121F0005_9700_HDTRA114D0008_9700
Leidos, Inc.: all federal awards · Department of Defense: spending · Defense Threat Reduction Agency: what it buys
NUCLEAR, CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET
What it is
- Product or service
- National Defense R&D Services; Defense-Related Activities; Applied Research (PSC AC32)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Biotechnology) (NAICS 541712)
- Contracting office
- Defense Threat Reduction Agency (HDTRA1)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Cost plus fixed fee
- How it was bought
- Multiple-award IDIQ · under HDTRA114D0008
- Solicitation
- HDTRA112R0016
- Where the work is
- Fairfax, VA · district VA-08
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
2 subawards totaling $67.8K (0.4% of what was obligated), as Leidos, Inc. reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Dagson Consulting, LLC | $67.8K | 2 | NE | 2022-12-21 | 2023-01-18 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2022-12-21 | Dagson Consulting, LLC | $35.0K | PROCURED GOODS AND/OR SERVICES BETWEEN 01-DEC-22 AND 31-DEC-22 IN SUPPORT OF CONTRACT SOW. |
| 2023-01-18 | Dagson Consulting, LLC | $32.8K | PROCURED GOODS AND/OR SERVICES BETWEEN 01-JAN-23 AND 31-JAN-23 IN SUPPORT OF CONTRACT SOW. |
Every action
20 actions since 2022-12-05. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-09-22 | P00027 | Funding only | $171.6K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-08-07 | P00026 | Supplemental agreement (work within scope) | $405.6K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-07-24 | P00025 | Funding only | $160.0K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-06-11 | P00024 | Funding only | $136.1K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-04-01 | P00023 | Funding only | $784.4K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-04-01 | P00022 | Administrative change | $0 | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-03-13 | P00021 | Administrative change | $0 | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2025-01-23 | P00020 | Option exercised | $250.9K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2024-11-26 | P00019 | Funding only | $1.45M | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2024-11-19 | P00018 | Funding only | -$350.0K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2024-07-15 | P00017 | Option exercised | $3.27M | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2024-05-29 | P00016 | Funding only | $1.22M | NUCLEAR CHEMICAL BIOLOGICAL RADIOLOGICAL EXPLOSIVE ANALYSIS TOOLSET |
| 2024-01-25 | P00015 | Option exercised | $2.60M | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2023-11-16 | P00014 | Funding only | $900.0K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2023-08-03 | P00013 | Option exercised | $2.47M | NUCLEAR, CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND EXPLOSIVES ANALYSIS TOOLSET |
| 2023-05-31 | P00012 | Funding only | $500.0K | NUCLEAR, CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND EXPLOSIVES ANALYSIS TOOLSET |
| 2023-04-05 | P00011 | Option exercised | $525.7K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2022-12-14 | P00010 | Option exercised | $500.0K | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2022-12-07 | P00009 | Funding only | $2.33M | NUCLEAR, CHEMICAL, BIOLOGICAL, AND HIGH EXPLOSIVE ANALYSIS TOOLSET |
| 2022-12-05 | P00008 | Administrative change | $0 | THE PRIMARY OBJECTIVE IS TO DEVELOP AND DEPLOY A MODERN, SCALABLE AND TAILORABLE CLOUD-READY FRAMEWORK INTEGRATED WITH PLANNING, CONSEQUENCE ASSESSMENT, INFORMATION ANALYTICS, WAR GAMING AND COURSE OF ACTIONS CAPABILITIES. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗